Tag Archives: SAGE

Top 20 Undervalued Stocks by Market Cap Class March 2021: Health Care

What are the top 20 Undervalued Stocks (selected over 5 market cap classes) in the Health Care Sector? I have used the analysis tools on the website stockcalc.com to generate the content of this blog post. Have a look down the Welcome page www.stockcalc.com/Welcome for some of the free lists and reports available.

Or start your StockCalc 30 Day Free Trial

Undervalued Stocks – Health Care Sector

Today our focus is the Health Care sector and we are looking at companies that are undervalued based on our Weighted Average Valuation (WAV) calculation which we do for the 8000 stocks each night in the StockCalc database. The Health Care sector is comprised of companies in the following Industry groups: Biotechnology, Drug Manufacturers, Healthcare Plans, Providers & Services, Medical Devices, Instruments, Diagnostics, Research and Distribution. Companies in this Sector range in activities from research and discovery through to development and production of innovative drug and drug related technologies. They also include medical software, diagnostics, equipment, retail drug sales through to managed health products and services. The mature companies in this sector tend to have steady revenues and earnings through the economic cycles. The stocks are also held for their dividends.

We generate our Weighted Average Valuation (WAV) from 5 models and Analyst consensus. Overview of the models used: Discounted Cash Flow (DCF value) is a valuation technique where cash flow projections are discounted back to the present to calculate value per share. A Comparables model values the company on the basis of ratios from selected comparable companies. We actually do 3 types of comparables models. An Adjusted Book Value (ABV) is calculated by multiplying book value per share by its historical Price to Book ratio. If we have Analyst coverage we look at the consensus target price.

Today’s Data – Health Care

In the table below we can see the close price (Mar 15th 2021) and valuation for these companies along with the ratio of valuation to price as well as their market cap class and average trading volume.

Symbol Company Name Close Price($) Valuation ($) Value/ Price Class Average Volume
GRFS-Q Grifols 16.05 25.46 1.59 Large Cap 1252042
REGN-Q Regeneron Pharmaceuticals 483.94 670.01 1.38 Large Cap 725117
VRTX-Q Vertex Pharmaceuticals 219.65 281.29 1.28 Large Cap 1539755
FMS-N Fresenius Medical Care 36.32 45.43 1.25 Large Cap 514545
GSK-N GlaxoSmithKline 35.88 44.13 1.23 Large Cap 6011590
OPK-Q OPKO Health 4.72 6.11 1.29 Mid Cap 9264797
CMD-N Cantel Medical 78.43 100.00 1.28 Mid Cap 755123
GLPG-Q Galapagos 83.08 106.05 1.28 Mid Cap 142367
SAGE-Q Sage Therapeutics 79.32 99.00 1.25 Mid Cap 400545
EXEL-Q Exelixis 24.17 29.91 1.24 Mid Cap 2098945
SUPN-Q Supernus Pharmaceuticals 26.80 54.25 2.02 Small Cap 282360
CPRX-Q Catalyst Pharmaceuticals 3.94 7.27 1.84 Small Cap 1443936
CHRS-Q Coherus BioSciences 15.86 27.37 1.73 Small Cap 823515
CO-N Global Cord Blood 4.58 6.66 1.45 Small Cap 59174
GUD-T Knight Therapeutics 5.20 7.19 1.38 Small Cap 508236
HAPP-Q Happiness Biotech Gr 2.08 3.97 1.91 Micro Cap 316488
DR-T Medical Facilities 6.76 9.30 1.38 Micro Cap 77223
VYGR-Q Voyager Therapeutics 5.80 6.77 1.17 Micro Cap 422267
LABS-T MediPharm Labs 0.53 0.61 1.16 Micro Cap 4424442
CRHM-A CRH Medical 3.89 4.45 1.14 Micro Cap 375956
DN-T Delta 9 Cannabis 0.52 0.57 1.10 Nano Cap 245179

N-NYSE, Q-Nasdaq, A-American, T-Toronto, X-Toronto Venture

Lets look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Cantel Medical

Cantel Medical Corp is dedicated in delivering infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.

Medical Facilities

Medical Facilities Corp is engaged in controlling interests, through its subsidiaries, in specialty hospitals and an ambulatory surgery center. The specialty surgical hospitals perform scheduled surgical, imaging and diagnostic procedures.

Generate lists and valuations like this in StockCalc – have a look here (Free Trial)

Alphabet (GOOG:NAS) and Gilead Sciences (GILD:NAS) Are Undervalued

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Undervalued Stocks on NASDAQ

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
GOOGL Alphabet Inc 2017 840.030000 981.8333 USD 12
GOOG Alphabet Inc 2017 820.450000 981.8333 USD 12
AMZN Amazon.com Inc 2017 836.390000 949.3636 USD 11
GILD Gilead Sciences Inc 2017 67.550000 98.6667 USD 3
PCLN The Priceline Group Inc 2017 1637.290000 1751.4290 USD 7
BIIB Biogen Inc 2017 285.140000 333.0000 USD 6
SHPG Shire PLC 2017 172.320000 230.0461 USD 2
REGN Regeneron Pharmaceuticals Inc 2017 376.520000 458.0000 USD 4
ALXN Alexion Pharmaceuticals Inc 2017 129.500000 161.0000 USD 3
ISRG Intuitive Surgical Inc 2017 714.920000 761.6667 USD 3
EQIX Equinix Inc 2017 382.640000 420.0000 USD 2
ORLY O’Reilly Automotive Inc 2017 269.520000 308.2000 USD 5
EXPE Expedia Inc 2017 119.670000 150.5714 USD 7
ULTA Ulta Beauty Inc 2018 271.460000 305.7500 USD 4
ULTI The Ultimate Software Group Inc 2017 196.280000 239.5714 USD 7
LOGM LogMeIn Inc 2017 94.350000 125.0000 USD 1
RGLD Royal Gold Inc 2017 71.280000 116.8240 CAD 2
ICPT Intercept Pharmaceuticals Inc 2017 126.960000 190.8000 USD 5
ACIA Acacia Communications Inc 2017 65.710000 125.0000 USD 1
MSTR MicroStrategy Inc 2017 192.990000 225.5000 USD 2
SAGE Sage Therapeutics Inc 2017 54.330000 110.0000 USD 1
AGIO Agios Pharmaceuticals Inc 2017 46.380000 82.5000 USD 2
SRPT Sarepta Therapeutics Inc 2017 28.270000 82.0000 USD 3
GBT Global Blood Therapeutics Inc 2017 22.400000 60.0000 USD 2
ATRA Atara Biotherapeutics Inc 2017 15.750000 47.0000 USD 1

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

GOOG:NAS Alphabet

Alphabet has 72053 employees and is headquartered in United States.
Alphabet Inc through its subsidiary Google Inc is engaged in improving the ways people connect with information & products including Search, Android, YouTube, Apps, Maps & Ads. It also produces internet-connected home devices & provides internet services.

GILD:NAS Gilead Sciences

Gilead Sciences has 8000 employees and is headquartered in United States.
Gilead Sciences Inc is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.